explore -WSS

explore

author：Wikipedia 2025-10-01 11:02:43 - browse：3646

Jeremey Wyatt ActiGraph

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry.

The Pensacola, Fla.-based company creates devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.

There are many potential advantages to using wearables in clinical trials. Continuous data may collect a more comprehensive picture of how a patient responds to treatment and could help drugmakers complete trials faster with fewer participants. But risk-averse companies have been slow to adopt the technology and opt instead for the certainty of established methods for capturing data. The industry has yet to see a drug approved with evidence from a wearable device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Fetal cell organoids grown from amniotic fluid, study finds

focus

WSS

Readers discuss the intersection of pregnancy and addiction

Cheap, fast test for Zika and dengue could cost just $1

Longer MASH drug regimen improved liver, Akero study finds

Study: Why relieving medical debt did not improve financial outcomes

Cigna wins case to block Amy Bricker's move to CVS

California wildfire smoke linked to 52,000 early deaths, study says

hotspot

explore

focus

Medicare details structure of new drug price negotiation program

Families look for replacement for GSK asthma drug Flovent

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Immune cells and nerve overgrowth may explain recurring UTI pain

Continuity nursing helped my family in our darkest PICU moments

Biden's 'march

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readers discuss the intersection of pregnancy and addiction

Guidelines to prevent youth baseball injuries need more muscle

Teladoc has a new CEO, but challenges remain the same

entertainment

State of the Union pitch: Bigger Medicare drug price negotiations

Fetal cell organoids grown from amniotic fluid, study finds

Stem cell biologist probes earliest stages of human development

First over

Lilly's Alzheimer's drug donanemab backed by FDA advisers

For AI in health care standards, federal regulators join with industry group

Wikipedia

focus

focus

focus